Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases
Open Access
- 25 November 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Abstract
Disease-modifying therapies (DMTs) are widely used in neuroimmunological diseases such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Although these treatments are known to predispose patients to infections and affect their responses to vaccination, little is known about the impact of DMTs on the myeloid cell compartment. In this study, we use mass cytometry to examine DMT-associated changes in the innate immune system in untreated and treated patients with MS (n = 39) or NMOSD (n = 23). We also investigated the association between changes in myeloid cell phenotypes and longitudinal responsiveness to homologous primary, secondary, and tertiary SARS-CoV-2 mRNA vaccinations. Multiple DMT-associated myeloid cell clusters, in particular CD64+HLADRlow granulocytes, showed significant correlations with B and T cell responses induced by vaccination. Our findings suggest the potential role of myeloid cells in cellular and humoral responses following vaccination in DMT-treated patients with neuroimmunological diseases.Keywords
This publication has 45 references indexed in Scilit:
- The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis OpticaBrain Pathology, 2013
- Rhythmic Modulation of the Hematopoietic Niche through Neutrophil ClearanceCell, 2013
- Myasthenia gravis and neuromyelitis optica spectrum disorderNeurology, 2012
- Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161Nature Immunology, 2011
- Control systems and decision making for antibody productionNature Immunology, 2010
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivoAnnals of Neurology, 2009
- A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onsetNeurology, 2009
- Ligation of CD8α on human natural killer cells prevents activation‐induced apoptosis and enhances cytolytic activityImmunology, 2005
- In Vivo Activation of Antigen-Specific CD4 T CellsAnnual Review of Immunology, 2001